Share on facebook Share on Twitter Share on Google Plus Share This
Back to Results

Determination of incidence and risk factors for colon problems in patients with CF


Title A Long Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients with Cystic Fibrosis (CF) Treated with Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors
Therapeutic Area Cystic Fibrosis
Principal Investigator Scott Schroeder, MD
Gender All
Contact Scott Schroeder
617 636-7917
More Information https://clinicaltrials.gov/ct2/show/NCT01652157

Overview

This is a prospective observational study to determine the incidence of fibrosing colonpathy in patients with CF.

Study Details

Inclusion Criteria

  • Patients must have diagnosis of Cystic Fibrosis and take pancreatic enzyme supplements

Exclusion Criteria

Study Requirements

Observational study. There are no tests and no x-rays.